These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 3742433

  • 1. Regulation of pulsatile secretion of progesterone during the human luteal phase.
    Steele PA, Braund W, Judd SJ.
    Clin Reprod Fertil; 1986 Apr; 4(2):117-24. PubMed ID: 3742433
    [Abstract] [Full Text] [Related]

  • 2. Synchronous secretion of luteinizing hormone and prolactin in the human luteal phase: neuroendocrine mechanisms.
    Braund W, Roeger DC, Judd SJ.
    J Clin Endocrinol Metab; 1984 Feb; 58(2):293-7. PubMed ID: 6420434
    [Abstract] [Full Text] [Related]

  • 3. [Pulsatile secretion of prolactin during the human menstrual cycle].
    Masaoka K, Kitazawa M, Niibe T, Kumasaka T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1793-9. PubMed ID: 3209907
    [Abstract] [Full Text] [Related]

  • 4. The source of pulsatile secretion of progesterone during the human follicular phase.
    Judd S, Terry A, Petrucco M, White G.
    J Clin Endocrinol Metab; 1992 Feb; 74(2):299-305. PubMed ID: 1730808
    [Abstract] [Full Text] [Related]

  • 5. The corpus luteum: determinants of progesterone secretion in the normal menstrual cycle.
    Soules MR, Clifton DK, Steiner RA, Cohen NL, Bremner WJ.
    Obstet Gynecol; 1988 May; 71(5):659-66. PubMed ID: 3357651
    [Abstract] [Full Text] [Related]

  • 6. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
    Cook CB, Nippoldt TB, Kletter GB, Kelch RP, Marshall JC.
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
    [Abstract] [Full Text] [Related]

  • 7. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
    Sartorio A, Pizzocaro A, Liberati D, De Nicolao G, Veldhuis JD, Faglia G.
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
    [Abstract] [Full Text] [Related]

  • 8. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion.
    Filicori M, Butler JP, Crowley WF.
    J Clin Invest; 1984 Jun; 73(6):1638-47. PubMed ID: 6427277
    [Abstract] [Full Text] [Related]

  • 9. Different effects of subnormal levels of progesterone on the pulsatile and surge mode secretion of luteinizing hormone in ovariectomized goats.
    Kim S, Tanaka T, Kamomae H.
    Biol Reprod; 2003 Jul; 69(1):141-5. PubMed ID: 12606364
    [Abstract] [Full Text] [Related]

  • 10. Naloxone-induced prolactin secretion in women: evidence against a direct prolactin stimulatory effect of endogenous opioids.
    Cetel NS, Quigley ME, Yen SS.
    J Clin Endocrinol Metab; 1985 Jan; 60(1):191-6. PubMed ID: 3964791
    [Abstract] [Full Text] [Related]

  • 11. Sustained effects of opioid antagonism during the normal human luteal phase.
    Gindoff PR, Jewelewicz R, Hembree W, Wardlaw S, Ferin M.
    J Clin Endocrinol Metab; 1988 May; 66(5):1000-4. PubMed ID: 3129443
    [Abstract] [Full Text] [Related]

  • 12. Diurnal patterns of pulsatile luteinizing hormone secretion in hypothalamic amenorrhea: reproducibility and responses to opiate blockade and an alpha 2-adrenergic agonist.
    Khoury SA, Reame NE, Kelch RP, Marshall JC.
    J Clin Endocrinol Metab; 1987 Apr; 64(4):755-62. PubMed ID: 2880864
    [Abstract] [Full Text] [Related]

  • 13. Reduced frequency of pulsatile luteinizing hormone secretion in the luteal phase of the rhesus monkey. Involvement of endogenous opiates.
    Van Vugt DA, Lam NY, Ferin M.
    Endocrinology; 1984 Sep; 115(3):1095-101. PubMed ID: 6745188
    [Abstract] [Full Text] [Related]

  • 14. Ovariectomy during the luteal phase influences secretion of prolactin, growth hormone, and insulin-like growth factor-I in the bitch.
    Lee WM, Kooistra HS, Mol JA, Dieleman SJ, Schaefers-Okkens AC.
    Theriogenology; 2006 Jul 15; 66(2):484-90. PubMed ID: 16442609
    [Abstract] [Full Text] [Related]

  • 15. Changes in the ovarian dynamics and endocrine profiles in goats treated with a progesterone antagonist during the early luteal phase of the estrous cycle.
    Suganuma C, Kuroiwa T, Tanaka T, Kamomae H.
    Anim Reprod Sci; 2007 Oct 15; 101(3-4):285-94. PubMed ID: 17027203
    [Abstract] [Full Text] [Related]

  • 16. A potential role of endogenous progesterone in modulation of GH, prolactin and thyrotrophin secretion during normal menstrual cycle.
    Caufriez A, Leproult R, L'Hermite-Balériaux M, Moreno-Reyes R, Copinschi G.
    Clin Endocrinol (Oxf); 2009 Oct 15; 71(4):535-42. PubMed ID: 19222493
    [Abstract] [Full Text] [Related]

  • 17. Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone.
    Rapkin AJ, Shoupe D, Reading A, Daneshgar KK, Goldman L, Bohn Y, Brann DW, Mahesh VB.
    J Soc Gynecol Investig; 1996 Oct 15; 3(2):93-8. PubMed ID: 8796815
    [Abstract] [Full Text] [Related]

  • 18. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia.
    Larrea F, Sandoval JL, Salinas E, Franco-Rodriguez VA, Méndez I, Ulloa-Aguirre A.
    Clin Endocrinol (Oxf); 1995 Nov 15; 43(5):591-600. PubMed ID: 8548944
    [Abstract] [Full Text] [Related]

  • 19. The effect of luteal phase estrogen antagonism on luteinizing hormone pulsatility and luteal function in women.
    Maruncic M, Casper RF.
    J Clin Endocrinol Metab; 1987 Jan 15; 64(1):148-52. PubMed ID: 3782428
    [Abstract] [Full Text] [Related]

  • 20. The effects of prolonged, intracerebroventricular prolactin treatment on luteinizing hormone secretion, catecholaminergic activity and estrous behavior in ewes.
    Misztal T, Romanowicz K, Tomaszewska-Zaremba D, Wójcik-Gładysz A, Barcikowski B.
    Exp Clin Endocrinol Diabetes; 2004 Apr 15; 112(4):215-21. PubMed ID: 15127327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.